| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Exhibit List - Exhibit 24 - Power of Attorney; Chief Legal and Strategy Officer | Stock Option (Right to Buy) | 350,000 | 20 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | 20 Jan 2026 | 1 | $0 | 4 | Exhibit List - Exhibit 24 - Power of Attorney; Chief Legal and Strategy Officer | 22 Jan 2026, 17:19 |
| TCRX | TScan Therapeutics, Inc. | 23 Aug 2024 | 9 | -$420,595 | 4 | Chief Legal and Strategy Officer | 27 Aug 2024, 18:46 |
| TCRX | TScan Therapeutics, Inc. | 12 Jan 2024 | 2 | $0 | 4 | Chief Legal and Strategy Officer | 11 Feb 2025, 17:54 |
| TCRX | TScan Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Chief Legal Officer | 15 Jun 2023, 18:01 |
| TCRX | TScan Therapeutics, Inc. | 02 Feb 2023 | 1 | $0 | 4 | Chief Legal Officer | 06 Feb 2023, 16:15 |
| TCRX | TScan Therapeutics, Inc. | 25 Jul 2022 | 1 | $0 | 4 | Chief Legal Officer | 27 Jul 2022, 16:30 |
| TCRX | TScan Therapeutics, Inc. | 18 Jan 2022 | 1 | $0 | 4 | Chief Legal Officer | 20 Jan 2022, 15:25 |
| TCRX | TScan Therapeutics, Inc. | 23 Sep 2021 | 1 | +$35,255 | 4 | Chief Legal Officer | 27 Sep 2021, 17:22 |
| TCRX | TScan Therapeutics, Inc. | 07 Sep 2021 | 1 | $0 | 4 | Chief Legal Officer | 09 Sep 2021, 17:21 |
| TCRX | TScan Therapeutics, Inc. | 07 Sep 2021 | 0 | $0 | 3 | Chief Legal Officer | 09 Sep 2021, 17:19 |